首页> 美国卫生研究院文献>The Eurasian Journal of Medicine >Prognostic Factors and Long-Term Efficacy of Tonsillectomy in 17 Patients with Pustulotic Arthro-Osteitis
【2h】

Prognostic Factors and Long-Term Efficacy of Tonsillectomy in 17 Patients with Pustulotic Arthro-Osteitis

机译:扁桃体炎性骨关节炎17例扁桃体切除术的预后因素和远期疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this case study, we aimed to evaluate the disease condition of patients with pustulotic arthro-osteitis (PAO) at 36-month post-tonsillectomy. A retrospective analysis of the cases of 17 patients with PAO who were resistant to initial systemic treatments and underwent tonsillectomy at our hospital in 2006–2016 was conducted. The patients’ disease condition at 1-, 24-, and 36-month post-tonsillectomy was assessed by the visual analog scale (VAS) score for osteoarthropathic pain, the disease duration, the area of palmoplantar lesions, and the Palmoplantar Pustular Psoriasis Area Severity Index (ppPASI). In the minimum follow-up of 36-month post-tonsillectomy in 17 patients, the median ppPASI and VAS scores decreased from 12 to 1 and from 80 to 20, respectively. Thirteen patients with ≥70% improvement in their VAS scores maintained the same good condition after ≥36 months, whereas four patients with <70% improvement in their VAS scores did not show remarkable improvement after that time point. Furthermore, we found that the improvement in VAS score was not associated with the disease duration or the patients’ pre-tonsillectomy ppPASI values. Tonsillectomy might be an alternative treatment option for patients with PAO. Long-term efficacy against pain can be predicted by evaluating a patient’s improvement at 1-month post-tonsillectomy.
机译:在本案例研究中,我们旨在评估扁桃体切除术后36个月的脓疱性关节炎(PAO)患者的疾病状况。回顾性分析2006-2016年我院对17例最初的全身治疗耐药并接受扁桃体切除术的PAO患者的病例。通过视觉模拟量表(VAS)评分评估骨关节炎的疼痛,疾病的持续时间,掌plant病变区域和掌plant脓疱性牛皮癣面积,评估扁桃体切除术后1、24和36个月的患者疾病状况严重性指数(ppPASI)。在17例扁桃体切除术后36个月的最小随访中,ppPASI和VAS评分中位数分别从12分降至1分和从80分降至20分。 13例VAS评分改善≥70%的患者在≥36个月后保持相同的良好状态,而4例VAS评分改善≤70%的患者在该时间点后未显示明显改善。此外,我们发现VAS分数的改善与疾病持续时间或患者扁桃体切除术前ppPASI值无关。扁桃体切除术可能是PAO患者的另一种治疗选择。可以通过评估扁桃体切除术后1个月患者的病情改善来预测长期的止痛效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号